https://www.selleckchem.com/pr....oducts/Belinostat.ht
Patients with malignant pleural mesothelioma (MPM) have a life-limiting illness and short prognosis and experience many debilitating symptoms from early in the illness. Innovations such as remote symptom monitoring are needed to enable patients to maintain wellbeing and manage symptoms in a proactive and timely manner. The Advanced Symptom Management System (ASyMS) has been successfully used to monitor symptoms associated with cancer. This study aimed to determine the feasibility and acceptability of using an ASyMS adapted for use by
Gefällt mir
Kommentar
Teilen
